lobbying_activities: 1109070

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1109070	f2ce45fe-2461-4591-9db2-f86c7edcd1e5	Q2	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2011	second_quarter	MED	Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Met with FDA officials regarding programs to support development of products for rare diseases.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2011-07-11T11:18:04.190000-04:00